We, JW Holdings, are moving forward toward the global Healthcare group and concentrating all our efforts to ensure stable growth of business companies including JW Pharmaceutical, JW Shinyak, JW Life Science and JW Medical. We directly handle overseas business for raw materials, finished pharmaceuticals, medical device etc. produced by our subsidiaries. We also generate profits from management services, subsidiaries’ equity interest, brand royalties and service fees from subsidiary companies. Moreover, JW Holdings focuses on establishing a vision so each business unit can gain competitiveness and create synergies that grows into a global Healthcare group.

Established since 1996, JW Holdings Corporation Representative Office (former JW Pharmaceutical Representative Office) has received the high appraisal of doctors & pharmacists. We commit to make our society bright and healthy by producing and supplying innovative technologies, products and services which will support for healthy life of the people, and will pursue the satisfaction and happiness of customers, shareholders and the employees through our trustworthy activities. Based on our innovative technology, we are poised to become a global health care group that extends beyond Korea to the world's manufacturing and marketing of medicines, cosmetics, patient-only foods, and Plant Engineering.